(Q53709398)

18 May 2018

title

Serum uric acid and related factors in 500 hospitalized subjects. (English)

1 reference

18 May 2018

1 reference

F Saggiani

1

1 reference

18 May 2018

S Pilati

2

1 reference

18 May 2018

G Targher

3

1 reference

18 May 2018

P Branzi

4

1 reference

18 May 2018

M Muggeo

5

1 reference

18 May 2018

E Bonora

6

1 reference

18 May 2018

publication date

1 December 1996

1 reference

18 May 2018

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

18 May 2018

volume

45

1 reference

18 May 2018

issue

12

1 reference

18 May 2018

page(s)

1557-1561

1 reference

18 May 2018

Serum uric acid in 23,923 men and gout in a subsample of 4257 men in France

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Uric acid: a risk factor for coronary heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Epidemiology of serum uric acid and gout in Frenchmen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Diabetes Mellitus in Patients With Gout

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Serum uric acid: correlation with biochemical, anthropometric, clinical and behavioral parameters in 10,000 Israeli men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Elevated serum uric acid--a facet of hyperinsulinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Effect of oestrogen therapy on plasma and urinary levels of uric acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Plasma follicle-stimulating hormone, luteinizing hormone, and sex hormones in patients with gout.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Estrogen‐Androgen Levels in Aging Men and Women: Therapeutic Considerations*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Gout, Hyperlipidemia, and Diabetes Interrelationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Uric acid and diabetes: observations in a population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

Serum uric acid in essential hypertension: an indicator of renal vascular involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990188-2

10.1016/S0026-0495(96)90188-2

7 January 2021

Identifiers

DOI

1 reference

18 May 2018

PubMed ID

8969292

1 reference

18 May 2018